RCD advises on iomed’s €10m financing round

RCD has advised IOMED, a leading company in artificial intelligence, for the activation of health data in a Series A investment round for a total of 10 million euros.

With this round, the company seeks to expand internationally and consolidate its position as an industry benchmark with a unique and differential value proposition in the field of artificial intelligence.

Philips Ventures, the investment group of healthcare technology leader Philips, and XTX Ventures, the investment arm of XTX Markets, a leading algorithmic trading firm, led the financing round. Fondo Bolsa Social and Redseed also participated, as well as IOMED’s existing investors Adara Ventures and EASO Ventures.

A team led by Josu Ibarzabal and Kevin Pallarés from the innovation and entrepreneurship area have been in charge of advising on this transaction.